The role of neurotransmitters in glioblastoma multiforme‐associated seizures
- 10 August 2023
- journal article
- review article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 83 (8) , 677-690
Abstract
GBM, or glioblastoma multiforme, is a brain tumor that poses a great threat to both children and adults, being the primary cause of death related to brain tumors. GBM is often associated with epilepsy, which can be debilitating. Seizures and the development of epilepsy are the primary symptoms that have a severe impact on the quality of life for GBM patients. It is increasingly apparent that the nervous system plays an essential role in the tumor microenvironment for all cancer types, including GBM. In recent years, there has been a growing understanding of how neurotransmitters control the progression of gliomas. Evidence suggests that neurotransmitters and neuromodulators found in the tumor microenvironment play crucial roles in the excitability, proliferation, quiescence, and differentiation of neurons, glial cells, and neural stem cells. The involvement of neurotransmitters appears to play a significant role in various stages of GBM. In this review, the focus is on presenting updated knowledge and emerging ideas regarding the interplay between neurotransmitters and neuromodulators, such as glutamate, GABA, norepinephrine, dopamine, serotonin, adenosine, and their relationship with GBM and the seizures induced by this condition. The review aims to explore the current understanding and provide new insights into the complex interactions between these neurotransmitters and neuromodulators in the context of GBM‐related seizures.Keywords
This publication has 113 references indexed in Scilit:
- Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A1‐receptor activationEpilepsia, 2011
- Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor‐associated epilepsyEpilepsia, 2011
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Adenosine kinase as a target for therapeutic antisense strategies in epilepsyEpilepsia, 2011
- Glutamate and the biology of gliomasGlia, 2010
- Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomideNeuro-Oncology, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Prevention of pancreatic cancer by the beta-blocker propranololAnti-Cancer Drugs, 2009
- Incidence of gliomas by anatomic locationNeuro-Oncology, 2007
- The influence of bio-behavioural factors on tumour biology: pathways and mechanismsNature Reviews Cancer, 2006